Imatinib mesylate is a tyrosine kinase inhibitor primarily indicated for the treatment of chronic myelogenous leukemia and gastrointestinal stromal tumors, where it functions by inhibiting abnormal cell… Read more















Imatinib mesylate is a tyrosine kinase inhibitor primarily indicated for the treatment of chronic myelogenous leukemia and gastrointestinal stromal tumors, where it functions by inhibiting abnormal cell growth signals. This category provides a comprehensive range of reference standards, including the active pharmaceutical ingredient, essential for pharmaceutical analytical testing and rigorous quality control. Laboratories rely on these high-quality materials, such as pharmacopeial and non-pharmacopeial impurities, to perform precise impurity profiling and identify potential degradation products or byproducts during synthesis. Furthermore, the inclusion of stable isotope labelled compounds facilitates accurate quantification and method validation in complex matrices, ensuring compliance with regulatory standards. By offering these precise chemical references, this collection supports the development and stability assessment of pharmaceutical formulations throughout the product lifecycle.